课题基金 / 基金详情

Analysis of SOCS/CSI family in skin

Analysis of SOCS/CSI family in skin
皮肤SOCS/CSI家族分析
批准号:
13470173
负责人:
HASHIMOTO Koji
金额:
$9.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

HASHIMOTO Koji的其他基金

相似基金

相关文献

中文摘要
翻译
细胞因子信号转导抑制因子(SOCS)/细胞因子诱导SH2蛋白(CIS)是细胞因子诱导的蛋白,是STAT信号通路的负调控因子。我们研究了细胞因子的主要靶细胞之一角质形成细胞中STATs和SOCS/CIS家族的调控机制。干扰素γ(干扰素γ)作用3h后,SOCS1mRNA表达上调,48h后SOCS1mRNA表达增加8.1倍。在干扰素γ后1h,SOCS3mRNA表达上调,而在干扰素γ后6~12h,SOCS3/Cis3mRNA表达增加6.7倍。白介素6(IL-6)作用1h后,SOCS3/Cis3mRNA表达增强,而SOCS1/Jab mRNA表达不受IL-6诱导,IL-4作用1h后,SOCS1/JAB和Cis1mRNA表达分别增加3.4倍和5.1倍。转染腺病毒载体(AxCALNLJAB)可完全抑制干扰素γ依赖的STAT1磷酸化和IL-4依赖的STAT6磷酸化。转染AxCALNLJAB不能抑制依赖IL-6的STAT3的磷酸化--一些报道表明SOCS1/JAB是髓系白血病ML细胞中STAT3信号的有效抑制者。转染腺病毒载体可完全抑制IL-6依赖的STAT3的磷酸化,部分抑制干扰素γ依赖的STAT1的磷酸化。然而,转导AxCACIS3并不能抑制依赖IL-4的STAT6的磷酸化。转染腺病毒载体(AxCALNLCIS1)对正常角质形成细胞中的STAT1、STAT3和STAT6信号转导无影响。因此,STAT和SOCS之间的关系在角质形成细胞中是独一无二的,SOCS调节这些细胞中的细胞因子信号。
英文摘要
The suppressor of cytokine signaling (SOCS)/cytokine-inducible SH2 containing (CIS) proteins are cytokine-inducible and are negative regulators of the STAT signaling pathway. We investigated the mechanism regulating STATs and the SOCS/CIS family in keratinocytes, one of the major target cells for cytokines.SOCS1 mRNA was upregulated 3 h post- interferon γ(IFNγ), and a 8.1-fold increase in SOCS1 mRNA occurred 48 h post-IFNγ. SOCS3 mRNA was also upregulated from 1 h post-IFNγ, and a 6.7-fold increase in SOCS3/CIS3 mRNA occurred between 6 and 12 h post-INFγ. Interleukin-6 (IL-6) exposure for 1 h enhanced the expression of SOCS3/CIS3 mRNA, but SOCS1/JAB mRNA was not induced by IL-6, IL-4 upregulated SOCS1/JAB and CIS1 mRNA, with 3.4-and 5.1-fold increases in mRNA observed at 1 h post-IL-4, respectively. In contrast, epidermal growth factor(EGF), which phosphorylates STAT3, did not influence the level of SOCS/CIS family mRNA expression.Transfection of an adenovirus vector expressing SOCS1/JAB(AxCALNLJAB)completely inhibited IFNγ-dependent STAT1 phosphorylation and IL-4-dependent STAT6 phosphorylation. Transfection of AxCALNLJAB did not inhibit IL-6-dependent STAT3 phosphorylation-several reports show SOCS1/JAB is a potent inhibitor of STAT3 signaling in the myeloid leukemia Ml cell. Transfection of the adenovirus vector expressing SOCS3/CIS(AxCACIS3)completely inhibited IL-6-dependent STAT3 phosphorylation and partially inhibited IFNγ-dependent STAT1 phosphorylation. However, transfection of AxCACIS3 did not inhibit IL-4-dependent STAT6 phosphorylation. Transfection of the adenovirus vector expressing CIS1(AxCALNLCISl)had no effect on STAT1, STAT3, and STAT6 signaling in normal keratinocytes. Therefore, the relationship between STAT and SOCS is unique in the keratinocytes, and SOCS regulates cytokine signals in these cells.
期刊论文(46)
专著(0)
科研奖励(0)
会议论文
白方裕司, 橋本公二 等: "表皮細胞とシグナル伝達"現代医療. Vol.34. 1815-1822 (2002)
Yuji Shirakata、Koji Hashimoto 等:“表皮细胞和信号转导”现代医学第 34 卷(2002 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shouda T, Yoshida T, Hanada T, Wakioka T, Oishi M, Miyoshi K, Komiya S, Kosai K, Hanakawa Y, Hashimoto K, Nagata K, Yoshimura A: "Induction of the cytokine signal regulator SOC3/CIS3 as a therapeutic strategy for treating inflammatory arthritis"J Clin Inv
Shouda T、Yoshida T、Hanada T、Wakioka T、Oishi M、Miyoshi K、Komiya S、Kosai K、Hanakawa Y、Hashimoto K、Nagata K、Yoshimura A:“诱导细胞因子信号调节剂 SOC3/CIS3 作为治疗策略
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yamasaki K, Hashimoto K. et al.: "Keratinocyte growth inhibition by high-dose epidermal growth factor is mediated by transforming growth factor β autoinduction"J Invest Dermatol. Vol.120(In press). (2003)
Yamasaki K、Hashimoto K. 等人:“高剂量表皮生长因子对角质细胞生长的抑制是由转化生长因子 β 自诱导介导的”J Invest Dermatol 第 120 卷(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sayama K., Hashimoto K.et al.: "Phosphatidyl inositol 3 kinase is a key regulator of early phase differentiation in keratinocytes"J Biol Chem. Vol.277. 40390-40396 (2002)
Sayama K.、Hashimoto K.等人:“磷脂酰肌醇 3 激酶是角质形成细胞早期分化的关键调节因子”J Biol Chem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
22
    Development of cerebral infarction regenerative treatment by neural stem cell transplant targeting microRNA
    • 批准号:
      16K10715
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2016
    • 负责人:
      HASHIMOTO Koji
    • 依托单位:
    The role of a novel platelet activated receptor CLEC-2 in the carotid plaque
    • 批准号:
      25861265
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      HASHIMOTO Koji
    • 依托单位:
    Construction of new description of atomic nuclei using superstring theory
    Application of superstring theory to nuclear and quark physics
    国内基金
    海外基金
    乌司他丁靶向抑制HDAC1通过SOCS1/JAK2/STAT3 轴调控小胶质细胞极化来减轻局灶性脑缺血再灌注损伤的机制研究
    • 批准号:
      2026JJ81821
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      陈晓曦
    • 依托单位:
    去泛素化酶USP13稳定SOCS5调节自噬促进胶质母细胞瘤中的替莫唑胺耐药的机制研究
    去泛素化酶USP13通过调控SOCS1表达抑制小胶质细胞M1极化促进脑血管新生改善脑缺血再灌注损伤
    • 批准号:
      2026JJ81103
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      王京微
    • 依托单位:
    SOCS1调控RORγt/Foxp3信号轴激活Th17细胞免疫诱导过敏性紫癜的作用及机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      卢琴红
    • 依托单位: